Results of the October 2016 Innovation to Impact Grants competition

We are pleased to announce the results of the most recent Innovation to Impact Grants competition to support the further development of successful findings based on the goals originally explored through a CCSRI Innovation Grant. Below is a listing of newly awarded Innovation to Impact Grants.

Out of a total of 29 grant applications, 6 Canadian Cancer Society Innovation to Impact Grants have been approved – a 21% success rate. Funds committed to this competition have been made possible by the significant efforts of CCS donors and volunteers across the country and by funding partners. CCS and Brain Canada have partnered to support one grant focused on brain cancer research in this competition. This partnership leverages donations made to CCS with matching funds from Brain Canada through the Canada Brain Research Fund, a public-private partnership established by the Government of Canada,enabling more brain cancer research to be funded. These projects total almost $2.7 million in funding over the full term of these grants.

Summaries of awarded grants

 Please note: 

  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is February 1, 2017.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Allen-Vercoe, Emma
University of Guelph
Determining the virulence factors of Fusobacterium nucleatum to define diagnostic and therapeutic targets for colorectal cancer
2017/2018 :  $146,584
2018/2019 :  $146,583
2019/2020 :  $146,583
Bally, Marcel
BC Cancer Agency (Vancouver)
Copper-drug complexes for use in the treatment of aggressive cancers
2017/2018 :  $147,000
2018/2019 :  $147,000
2019/2020 :  $147,000
Cypel, Marcelo
The Toronto Hospital (General Division) - UHN
In vivo lung perfusion (IVLP) as an adjuvant treatment for patients undergoing surgical resection of pulmonary metastases of bone and soft tissue sarcomas
2017/2018 :  $147,000
2018/2019 :  $147,000
2019/2020 :  $147,000
Pause, Arnim
McGill University
Haploinsufficient loss of ESCRT components as new drivers of cancer
2017/2018 :  $147,000
2018/2019 :  $147,000
2019/2020 :  $147,000
Stanisz, Greg
Sunnybrook Research Institute
Quantitative MRI as a biomarker of tumour resistance to radiation treatment in brain metastasis
*co-funded with Brain Canada with the financial support of Health Canada
2017/2018 :  $147,000
2018/2019 :  $147,000
2019/2020 :  $147,000
Ursini-Siegel, Josie
Lady Davis Institute
Targeting tyrosine kinase signalling networks to reverse STAT family–driven breast cancer immune suppression
2017/2018 :  $147,000
2018/2019 :  $147,000
2019/2020 :  $147,000

Last modified on: February 6, 2017